Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Filippi

Showing results (181-190 of 1,315) with videos related to

Pageof 132
Sort By:
Multiple Sclerosis and Related Disorders|June 1, 2025
TSPO PET in multiple sclerosis: Emerging insights into pathophysiology, prognosis, and treatment monitoringGiorgio Guido, Paolo Preziosa, Massimo Filippi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 26, 2019
Imaging the migrainous brain: the present and the futureBruno Colombo, Roberta Messina, Maria Assunta Rocca, et al.
Neurology|September 19, 2007
A composite score to predict short-term disease activity in patients with relapsing-remitting MSMaria Pia Sormani, Marco Rovaris, Giancarlo Comi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 15, 2008
AgingSamantha Galluzzi, Alberto Beltramello, Massimo Filippi, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|April 12, 2007
MRI to monitor treatment efficacy in multiple sclerosisFranz Fazekas, Per Soelberg-Sorensen, Giancarlo Comi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 19, 2014
Rituximab as a first-line preventive treatment in pediatric NMOSDs: Preliminary results in 5 childrenGiulia Longoni, Brenda Banwell, Massimo Filippi, et al.
Journal of Neurology|November 19, 2021
Measuring social cognition in frontotemporal lobar degeneration: a clinical approachMaria Antonietta Magno, Elisa Canu, Federica Agosta, et al.
Neurology|October 17, 2022
Reader Response: Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Prospective Longitudinal Cohort StudyMassimo Filippi, Giordano Cecchetti, Edoardo Gioele Spinelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 7, 2024
Immune-mediated colitis: A class effect with anti-CD2O agents used to treat MS?Vittorio Viti, Chiara Zanetta, Maria A Rocca, et al.
Multiple Sclerosis and Related Disorders|July 5, 2025
Perivascular spaces in multiple sclerosis: Markers of neuroinflammation or footprints of vascular pathology?Lucrezia Rossi, Paolo Preziosa, Massimo Filippi, et al.
Pageof 132

Showing results (181-190 of 1,315) with videos related to

Sort By:
Pageof 132
Multiple Sclerosis and Related Disorders|June 1, 2025
TSPO PET in multiple sclerosis: Emerging insights into pathophysiology, prognosis, and treatment monitoringGiorgio Guido, Paolo Preziosa, Massimo Filippi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 26, 2019
Imaging the migrainous brain: the present and the futureBruno Colombo, Roberta Messina, Maria Assunta Rocca, et al.
Neurology|September 19, 2007
A composite score to predict short-term disease activity in patients with relapsing-remitting MSMaria Pia Sormani, Marco Rovaris, Giancarlo Comi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 15, 2008
AgingSamantha Galluzzi, Alberto Beltramello, Massimo Filippi, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|April 12, 2007
MRI to monitor treatment efficacy in multiple sclerosisFranz Fazekas, Per Soelberg-Sorensen, Giancarlo Comi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 19, 2014
Rituximab as a first-line preventive treatment in pediatric NMOSDs: Preliminary results in 5 childrenGiulia Longoni, Brenda Banwell, Massimo Filippi, et al.
Journal of Neurology|November 19, 2021
Measuring social cognition in frontotemporal lobar degeneration: a clinical approachMaria Antonietta Magno, Elisa Canu, Federica Agosta, et al.
Neurology|October 17, 2022
Reader Response: Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Prospective Longitudinal Cohort StudyMassimo Filippi, Giordano Cecchetti, Edoardo Gioele Spinelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 7, 2024
Immune-mediated colitis: A class effect with anti-CD2O agents used to treat MS?Vittorio Viti, Chiara Zanetta, Maria A Rocca, et al.
Multiple Sclerosis and Related Disorders|July 5, 2025
Perivascular spaces in multiple sclerosis: Markers of neuroinflammation or footprints of vascular pathology?Lucrezia Rossi, Paolo Preziosa, Massimo Filippi, et al.
Pageof 132